Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-13.87%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$36.1B
AUM Growth
-$8.74B
(-19%)
Cap. Flow
-$2.44B
Cap. Flow
% of AUM
-6.76%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
799
New
91
Increased
212
Reduced
361
Closed
95
Top Buys
| 1 |
GE Aerospace
GE
|
$279M |
| 2 |
Wayfair
W
|
$171M |
| 3 |
RTX Corp
RTX
|
$120M |
| 4 |
Burlington
BURL
|
$117M |
| 5 |
Sarepta Therapeutics
SRPT
|
$115M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$946M |
| 2 |
SHPG
Shire pic
SHPG
|
$470M |
| 3 |
Deere & Co
DE
|
$332M |
| 4 |
COL
Rockwell Collins
COL
|
$286M |
| 5 |
ANDV
Andeavor
ANDV
|
$221M |
Sector Composition
| 1 | Healthcare | 15.2% |
| 2 | Technology | 13.75% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 12.27% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
NetApp
NTAP
$23.7B
| $18.7M | 0.05% |
313,600
-26,300
| -8% | -$1.57M |
|
352
Hershey
HSY
$37.6B
| $18.6M | 0.05% |
173,785
-2,500
| -1% | -$268K |
|
353
American Express
AXP
$227B
| $18.6M | 0.05% |
195,050
-599,000
| -75% | -$57.1M |
|
354
Abeona Therapeutics
ABEO
$353M
| $18.6M | 0.05% |
104,000
+25,000
| +32% | +$4.46M |
|
|
BHVN
355
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.5M | 0.05% |
+500,000
| New | +$18.5M |
|
356
American Airlines Group
AAL
$8.63B
| $18.3M | 0.05% |
570,392
-2,906,022
| -84% | -$93.3M |
|
|
ABMD
357
DELISTED
Abiomed Inc
ABMD
| $18.2M | 0.05% |
56,016
+21,416
| +62% | +$6.96M |
|
358
Altice USA
ATUS
$1.05B
| $18.2M | 0.05% |
+1,100,000
| New | +$18.2M |
|
|
VAPO
359
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $18.1M | 0.05% |
+113,565
| New | +$18.1M |
|
|
RDS.A
360
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18.1M | 0.05% |
310,274
-175,000
| -36% | -$10.2M |
|
|
EIGR
361
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $18M | 0.05% |
59,167
+36,427
| +160% | +$11.1M |
|
362
VF Corp
VFC
$5.86B
| $18M | 0.05% |
268,350
-59,720
| -18% | -$4.01M |
|
363
Kellanova
K
$27.8B
| $17.9M | 0.05% |
335,088
+8,374
| +3% | +$448K |
|
364
Advanced Micro Devices
AMD
$245B
| $17.9M | 0.05% |
971,323
+60,000
| +7% | +$1.11M |
|
|
AMCIU
365
DELISTED
AMCI Acquisition Corp. Unit
AMCIU
| $17.9M | 0.05% |
+1,800,000
| New | +$17.9M |
|
366
Lumen
LUMN
$4.87B
| $17.8M | 0.05% |
1,177,809
-57,700
| -5% | -$874K |
|
|
VNTR
367
DELISTED
Venator Materials PLC
VNTR
| $17.7M | 0.05% |
+4,232,394
| New | +$17.7M |
|
368
Cintas
CTAS
$82.4B
| $17.6M | 0.05% |
419,600
-21,200
| -5% | -$890K |
|
369
Raymond James Financial
RJF
$33B
| $17.6M | 0.05% |
353,850
+100,800
| +40% | +$5M |
|
|
SEI
370
Solaris Energy Infrastructure, Inc.
SEI
$1.18B
| $17.4M | 0.05% |
1,435,367
+480,808
| +50% | +$5.81M |
|
371
Novartis
NVS
$251B
| $17.2M | 0.05% |
+223,200
| New | +$17.2M |
|
372
Arrowhead Research
ARWR
$4.02B
| $17.1M | 0.05% |
1,375,000
+475,000
| +53% | +$5.9M |
|
|
CPE
373
DELISTED
Callon Petroleum Company
CPE
| $17.1M | 0.05% |
263,136
-30,000
| -10% | -$1.95M |
|
374
Masco
MAS
$15.9B
| $17.1M | 0.05% |
583,300
-852,918
| -59% | -$24.9M |
|
|
CBAY
375
DELISTED
Cymabay Therapeutics
CBAY
| $17M | 0.05% |
2,160,150
+185,150
| +9% | +$1.46M |
|